KIF19 is a plus end-directed microtubule motor protein that regulates motile cilia length by mediating microtubule depolymerization at ciliary tips 1. As a member of the kinesin superfamily, KIF19 functions independently from other ciliary length-regulating factors including kinases DYF-5 and NEKL-1, working in concert with other depolymerizing kinesins like KLP-7 to control ciliary subcompartment architecture 1. Disease relevance encompasses multiple systems: KIF19 mutations have been identified in autosomal dominant polycystic kidney disease (ADPKD) tissues, where pathogenic variants in KIF19 were detected in all ADPKD samples analyzed, suggesting a role in ciliary dysfunction-associated kidney disease 2. Additionally, KIF19 has emerged as a novel candidate gene for congenital anomalies of the kidney and urinary tract (CAKUT), with biallelic variants identified in affected families 3. KIF19 variants are also associated with COVID-19 severity 4 and have been identified as candidate genes in unexplained fetal lethality 5. Clinically, elevated KIF19 expression correlates with improved prognosis in hepatocellular carcinoma, associated with longer overall survival times 6, and the gene appears as a prognostic marker in pancreatic cancer prediction models 7.